Please join us for the oral presentation and moderated discussion of the top 36 abstracts submitted to the 2022 Virtual Diabetes Technology Meeting. This session is free for all to attend.
Moderators
John C. Pickup, MA, DPhil, FRCPath
King’s College London School of Medicine, London, UK
Jane Jeffrie Seley, DNP, MPH, MSN, GNP, BC-ADM, CDCES, CDTC, FADCES
Weill Cornell Medicine, New York, New York, USA
8:30 Use of Ultra-Rapid Insulin Lispro with a Full Closed-Loop Insulin Delivery System: An In Silico Analysis
Jenny L. Diaz C., PhD, et al.
Presented by: Patricio Colmegna, PhD
8:34 Simdex Enables First-in-Human Trials of a Novel Automated Insulin Delivery System at Home
Stephen Patek, PhD
8:38 Prevention of Rebound Hypoglycemia in an Advanced Automated Insulin Delivery System
Maria Fernanda Villa-Tamayo, MS
8:42 Comparing Different Individualized Black-Box Models for Insulin Pump Faults Detection on Artificial Pancreas Data
Eleonora Manzoni, MSc et al.
8:46 Feasibility of a Prototype Dual Function Glucose Sensing and Insulin Delivering Cannula
Cheng Yi Yuan, MD et al.
8:50 Significant Reduction in Hyperglycemia and High Satisfaction with Use of Control-IQ Technology in Prior MDI and Basal-Only Insulin Users with Type 2 Diabetes
Carol J. Levy, MD, CDCES et al.
8:54 Q&A / Panel Discussion
9:15 End of Session
Moderators
Bruce Buckingham, MD
Stanford University, Stanford, California, USA
Jenise C. Wong, MD, PhD
University of California, San Francisco, San Francisco, California, USA
9:15 Once-Weekly Insulin Icodec vs Once-Daily Insulin Glargine U100 in Combination with Bolus Insulin in Individuals with Type 2 Diabetes on Basal-Bolus Regimens (ONWARDS 4)
Chantal Mathieu, MD, PhD et al.
9:19 A Novel Infusion Failure Detection Paradigm Based on Fluid Pressure and Supervised Learning
Luis E. Blanco, BChE et al.
9:23 Insulin Pump Disruption: Cause and Effect
Alexander M. Markov, MD et al.
9:27 In Vitro Validation of an Open Source, Ultra-Low-Cost (<US$100) Insulin Pump
Matthew Payne, BE(Hons) et al.
9:31 Ultra Low Cost, Ultra Low Power, Open Source Clockwork Insulin Pump
Francis Pooke, BE(Hons) et al.
9:35 Inhaled Insulin + AID Safely Reduced Glucose in the 2 Hours Following a Meal in Proof-of-Concept Study Data Subset
Kevin Kaiserman, MD et al.
9:39 Q&A / Panel Discussion
10:00 End of Session
Moderators
Ibrahim A. Hashim, MSc, PhD, DABCC, FIBMS, CSc, FACB
UT Southwestern, Dallas, Texas, USA
Andreas Thomas, PhD
Freelance Scientific Consultant
10:00 Next Generation Glucose Reference Platform - Data Supporting the Use of the Radiometer ABL90 Analyzer
Alejandra M. Pulido, MD et al.
10:04 Machine Learning Based Models for Estimating CGM Accuracy to Venous Plasma Glucose from Accuracy to Capillary Glucose
Arnaud Jacquin, PhD et al.
10:08 User Performance Evaluation and System Accuracy Assessment of Four Blood Glucose Monitoring Systems With Color Coding of Results
Stefan Pleus, MSc et al.
10:12 Open Access, Light Based, Wearable Glucose Sensor – a Low-Cost Equitable APS
Josephine A. Dixon, BE(Hons) et al.
10:16 Comparison of POCT Devices to Glucose Isotope Dilution Gas Chromatography - Mass Spectrometry Reference Measurement Procedure
Komal Dahya, BS et al.
10:20 Improving the Quality of Glucose Concentration Measurements by Recalibration
Stefan Pleus, MSc et al.
10:24 Q&A / Panel Discussion
10:45 End of Session
Moderators
Julia Mader, MD
Medical University of Graz, Graz, Germany
Viral N. Shah, MD
Barbara Davis Center for Diabetes, University of Colorado, Aurora, Colorado, USA
10:45 Real-World Digital Health Data Demonstrate the Utility of The Glycemia Risk Index (GRI) as a Composite CGM Metric
Junjie Luo, PhD et al.
Presented by: Mansur Shomali, MD, CM
10:49 Imputation Model for Glucose Values Out of Measuring Range for Continuous Glucose Monitoring
Mikkel T. Olsen, MD et al.
10:53 Development of Derivatization-Free ID-LC/MS/MS Method for Simultaneous Measurement of Human Serum Monosaccharides
Chui Y. Tse, MS et al.
10:57 Translating event history to expected glucose distribution
Mrunal Sontakke, B.S et al.
11:01 The Continuous Glucose Deviation Interval and Variability Analysis (CG-DIVA): An Illustrative Method for Continuous Glucose Monitoring System Accuracy Assessment
Manuel Eichenlaub, PhD et al.
11:05 Delivering Insulin by Glucose-Responsive Polymer-Based Microneedle Patch
Jackie F. Liu, B.Tech et al.
11:09 Q&A / Panel Discussion
11:30 End of Session
Moderators
Guillermo A. Arreaza-Rubin, MD
NIDDK/NIH, Bethesda, Maryland, USA
Robert Gabbay, MD, PhD
American Diabetes Association, Arlington, Virginia, USA
11:30 Smart Insulin Therapy Initiation in Insulin-Naïve Subjects with Type 2 Diabetes Using Machine Learning
Jacopo Bonet, MS et al.
11:34 Long-Term Glycemic and Patient-Reported Outcomes in Older Adults with Type 1 Diabetes Using Control-IQ Technology
Steph Habif, EdD, MS et al.
11:38 Diabetes Phenotypes Quantified via a Physiofunctional Model Fitted to Raw CGM Time Series Data
Robert Capps, PhD et al.
11:42 Simulating the Impact of Diabetes Therapy Engagement on Outcomes
Lane Desborough, MScEng et al.
11:46 Correlation of Hemoglobin A1c and Continuous Glucose Monitor Metrics in Diverse Populations of Youth with Diabetes
Meryl Nath, BA et al.
11:50 InPen™ System Use and Glycemic Outcomes in Older Adults
Glen H. Im, MS et al.
11:54 Q&A / Panel Discussion
12:15 End of Session
Moderators
Ananda Basu, MD, FRCP
University of Virginia, Charlottesville, Virginia, USA
Sultan A. Meo, MD, MBBS, PhD, FRCP
King Saud University College of Medicine, Riyadh, Saudi Arabia
12:15 Effect of Mobile Application Usage on TIR and TAR Within People with T1D and T2D: A Pilot Cohort Retrospective Study
Mikhalina Akulova, MSc et al.
12:19 Smartphone Camera to Image the Retina for Primary Care MDs and Diabetologists
Ethan Hintz et al.
12:23 Free Diabetes Apps and Health Literacy for Diabetic Patients
Kayla Israni et al.
12:27 Social Network Analysis of Diabetes and Glucose Monitoring Systems on Twitter Informed by ADCES7™ Framework
Nishant R. Jain, MS et al.
12:31 The Use of a Combined Real-Time CGM and Digital Health Solution Lowered A1C in People With Type 2 Diabetes
Abhimanyu Kumbara et al.
12:35 Sensor Controlled Diabetic Foot Ulcer Therapy – Next Generation Therapy of the Most Devastating Complication of Diabetes
Dirk Hochlenert, MD, PhD et al.
12:39 Q&A / Panel Discussion
13:00 End of Session